Taiwan Great Health Exhibition Centre Opens in Kuala Lumpur, Showcasing Healthcare Innovation
KUALA LUMPUR, MALAYSIA – June 24, 2025 – The Taiwan Great Health Exhibition Centre, established by the Taiwan External Trade Development Council (TAITRA) under the commission of the International Trade Administration, Ministry of Economic Affairs, Taiwan, officially opened its doors today at the MATRADE Exhibition and Convention Centre in Kuala Lumpur, Malaysia.

This new center is a hub for 12 leading Taiwanese enterprises, showcasing innovative technologies and solutions across various fields. These include AI smart healthcare, advanced medical devices, professional medical services, and aesthetic medicine and healthcare. The initiative aims to fully demonstrate the robust capabilities of Taiwan’s healthcare industry to the Malaysian public.

AM BioTech has also established its presence at the center. They’re featuring their full range of patented Bio-Pulsed Exosome products, “ExoGiov®.” These products are gaining significant attention for their remarkable efficacy in skin repair and hair volumizing, and they’re expected to bring innovative health and beauty solutions to the Malaysian market.

Related News Report：

• BIGCOWFM
• 健康时尚 Good Health
• KLSE Screener
• 南洋商报
• Natural Health
• 星洲日報

AM Biotech is excited to unveil two groundbreaking themes at this year’s “Asia Beauty & Healthcare Show” (part of the Asia Biotech Exhibition series): Cosmetic Hair Growth and CDMO (Targeting Various Diseases).

We proudly feature our internationally patented Bio-Pulsed Exosome biochemical pulse technology, with its core cosmetic ingredient, ExoGiov® Exosome. ExoGiov® not only boasts third-party validated efficacy in cosmetic hair growth but has also achieved a significant breakthrough this year with its ability to target various diseases, unlocking immense possibilities in regenerative medicine.

We warmly welcome brand owners and OEM partners to visit our booth and explore collaboration opportunities. Additionally, we cordially invite research institutions and medical organizations to join us in R&D partnerships, CDMO manufacturing, and to expand clinical and pre-clinical research, accelerating the market introduction of innovative technologies.

We look forward to your visit and to embarking on a new chapter in exosome technology together!

ExoGiov®, a cosmetic raw material developed by AM Biotech, is registered under the international INCI name: “Chicken Embryonic Mesenchymal Cell-Derived Extracellular Vesicles.”
The ingredient has been successfully listed in the EU CosIng database since 2022, recognized for its hair and skin conditioning functions.
Products formulated with ExoGiov® have already been notified under the EU Cosmetic Products Notification Portal (CPNP) and are backed by official CPNP registration numbers as well as complete Product Information Files (PIF).

ExoGiov®-based cosmetic products have been commercially available in the European market since 2023, and the successful CPNP compliance further strengthens its potential for broader market expansion across Europe.

For more information, please contact us at : service@ambiotech.asia

• EU CosIng database details

• ExoGivo ® Statement